These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16289503)

  • 21. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the frequency of TP53 gene codon 72 polymorphisms in Iranian patients with endometrial cancer.
    Ghasemi N; Karimi-Zarchi M; Mortazavi-Zadeh MR; Atash-Afza A
    Cancer Genet Cytogenet; 2010 Jan; 196(2):167-70. PubMed ID: 20082853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
    Mechanic LE; Marrogi AJ; Welsh JA; Bowman ED; Khan MA; Enewold L; Zheng YL; Chanock S; Shields PG; Harris CC
    Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Telomerase promoter mutations in human immunodeficiency virus-related conjunctiva neoplasia.
    Starita N; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2018 Mar; 16(1):77. PubMed ID: 29562930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Human Herpesvirus 8 Sequences in Conjunctiva Intraepithelial Neoplasia and Squamous Cell Carcinoma of Ugandan Patients.
    Starita N; Annunziata C; Waddell KM; Buonaguro L; Buonaguro FM; Tornesello ML
    Biomed Res Int; 2015; 2015():801353. PubMed ID: 26509162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility.
    Zhuo XL; Li Q; Zhou Y; Cai L; Xiang ZL; Yuan W; Zhang XY
    Arch Med Res; 2009 Oct; 40(7):625-34. PubMed ID: 20082880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.
    Bergamaschi G; Merante S; Orlandi E; Galli A; Bernasconi P; Cazzola M
    Haematologica; 2004 Jul; 89(7):868-9. PubMed ID: 15257943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract.
    Furihata M; Takeuchi T; Matsumoto M; Kurabayashi A; Ohtsuki Y; Terao N; Kuwahara M; Shuin T
    Clin Cancer Res; 2002 May; 8(5):1192-5. PubMed ID: 12006537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA.
    Gemignani F; Moreno V; Landi S; Moullan N; Chabrier A; Gutiérrez-Enríquez S; Hall J; Guino E; Peinado MA; Capella G; Canzian F
    Oncogene; 2004 Mar; 23(10):1954-6. PubMed ID: 14647431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
    Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
    Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
    Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of TP53 codon 72 polymorphism with cervical cancer risk in Chinese women.
    Jiang P; Liu J; Zeng X; Li W; Tang J
    Cancer Genet Cytogenet; 2010 Mar; 197(2):174-8. PubMed ID: 20193851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
    Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
    Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corneo-conjunctival carcinoma in Uganda.
    Waddell KM; Downing RG; Lucas SB; Newton R
    Eye (Lond); 2006 Aug; 20(8):893-9. PubMed ID: 16456599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela].
    Cañas M; Morán Y; Camargo ME; Rivero MB; Bohórquez A; Villegas V; Ramírez E; Rendón Y; Suárez A; Morales L; Useche E; Salazar S; Zambrano A; Ramírez A; Valderrama E; Briceño Z; Chiurillo MA
    Invest Clin; 2009 Jun; 50(2):153-61. PubMed ID: 19662811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The p53 codon 72 polymorphism and lung cancer risk.
    Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
    Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
    Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
    Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
    Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
    Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.